Sutro Biopharma Inc buy Wedbush
Start price
11.08.23
/
50%
€3.86
Target price
11.08.24
€10.95
Performance (%)
-7.77%
Price
07.05.24
€3.56
Summary
This prediction is currently active. With a performance of -7.77%, the BUY prediction for Sutro Biopharma Inc by Wedbush is down slightly. This prediction currently runs until 11.08.24. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sutro Biopharma Inc | 12.658% | 12.658% |
iShares Core DAX® | 3.178% | 0.980% |
iShares Nasdaq 100 | 2.972% | 0.925% |
iShares Nikkei 225® | 0.545% | -4.556% |
iShares S&P 500 | 2.367% | 0.833% |
Comments by Wedbush for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) had its price target lowered by analysts at Wedbush from $20.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Wedbush for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€7.38
03.04.25
03.04.25
-26.78%
07.05.24
07.05.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.58
26.03.24
26.03.24
€7.38
26.03.25
26.03.25
-23.58%
07.05.24
07.05.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.08
14.11.23
14.11.23
€11.07
14.11.24
14.11.24
68.27%
07.05.24
07.05.24
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.72
23.10.23
23.10.23
€11.29
23.10.24
23.10.24
27.94%
07.05.24
07.05.24